PVA TePla AG

Common Stock · EUR · XETRA

TPET212

Price

€43.4

-0.41%

Cap

€766.21M

Earnings

—

30d Trend

+23.8%

0NL1

Loading chart data...

0 days · % change from startPowered by Brain47

BRAIN47 SIGNAL

STRONG

Risk Level30

Momentum68

Technical54

Fund Quality71

Cost Efficiency67

Raw weighted: 66×Macro 0.99 (−1%)=65

RISK

30/100

90d Volatility

20.5%Moderate

ATR %

1.5%Normal

Max Drawdown (1Y)

-11.3%Resilient

MOMENTUM

68/100

12-1M Momentum

+18.7%Strong uptrend

6-1M Momentum

+4.9%Flat

1M Return

+4.9%Stable

TECHNICAL

54/100

RSI (14)

57.4Neutral

Price vs SMA200

+8.5%Bullish trend

MACD

+0.08Bullish momentum

Bollinger Band

78%Mid-range

SMA Cross

Death CrossDeath Cross

Trend Quality (KER)

0.200Noisy/choppy

FUND QUALITY

71/100

Replication

PhysicalHolds actual assets

Holdings

830 positionsHighly diversified

Domicile

CanadaCheck tax treaty

Yield

2.30% (Distributing)Moderate

COST EFFICIENCY

67/100

Expense Ratio

0.23%Low cost

Fund Size (AUM)

$1.1BMid-size

Macro: neutral (×0.99) - Fear/Greed: 65 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months51

3-12 months65

1-5+ years ★71

Long-term compounder — quality business with growth runway

BRAIN47'S ASSESSMENT

I rate PVA TePla AG at 65/100 — a STRONG reading on the Brain47 Signal. The strongest factor is fund quality at 71/100. I classify this as a growth position with the strongest thesis on a long-term horizon.

DETAILED ANALYSIS

Long-term compounder — quality business with growth runway. Fund Quality (71) and low-risk profile are the primary strengths. I classify this as a growth position — strong momentum combined with solid fundamentals points to capital appreciation.

growthScore: 65/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.